Mariko Ogura

1.5k total citations
112 papers, 1.1k citations indexed

About

Mariko Ogura is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mariko Ogura has authored 112 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Oncology, 74 papers in Pulmonary and Respiratory Medicine and 26 papers in Surgery. Recurrent topics in Mariko Ogura's work include Gastric Cancer Management and Outcomes (60 papers), Colorectal Cancer Treatments and Studies (51 papers) and Cancer Treatment and Pharmacology (27 papers). Mariko Ogura is often cited by papers focused on Gastric Cancer Management and Outcomes (60 papers), Colorectal Cancer Treatments and Studies (51 papers) and Cancer Treatment and Pharmacology (27 papers). Mariko Ogura collaborates with scholars based in Japan, United States and Australia. Mariko Ogura's co-authors include Keisho Chìn, Eiji Shinozaki, Mitsukuni Suenaga, Daisuke Takahari, Izuma Nakayama, Kensei Yamaguchi, Hiroki Osumi, Takeru Wakatsuki, Nobuyuki Mizunuma and Satoshi Matsusaka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mariko Ogura

103 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariko Ogura Japan 15 694 589 254 167 166 112 1.1k
Natsuko Okita Japan 20 855 1.2× 518 0.9× 271 1.1× 135 0.8× 278 1.7× 110 1.3k
Hiroki Osumi Japan 17 600 0.9× 488 0.8× 231 0.9× 320 1.9× 149 0.9× 103 985
Izuma Nakayama Japan 14 527 0.8× 450 0.8× 214 0.8× 119 0.7× 123 0.7× 108 820
Alessia Mennitto Italy 19 549 0.8× 479 0.8× 212 0.8× 225 1.3× 271 1.6× 59 1.0k
Guoqing Liao China 18 316 0.5× 502 0.9× 215 0.8× 237 1.4× 511 3.1× 56 1.2k
Yuichi Arimoto Japan 13 376 0.5× 313 0.5× 429 1.7× 165 1.0× 330 2.0× 35 1.0k
Anna Zamboli Italy 13 519 0.7× 401 0.7× 283 1.1× 117 0.7× 151 0.9× 19 821
Federico Buffoli Italy 19 478 0.7× 532 0.9× 618 2.4× 115 0.7× 171 1.0× 45 1.2k
Giacomo Puppa Switzerland 16 961 1.4× 340 0.6× 386 1.5× 125 0.7× 185 1.1× 50 1.3k
Yusuke Tajima Japan 17 414 0.6× 694 1.2× 640 2.5× 75 0.4× 143 0.9× 58 1.2k

Countries citing papers authored by Mariko Ogura

Since Specialization
Citations

This map shows the geographic impact of Mariko Ogura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariko Ogura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariko Ogura more than expected).

Fields of papers citing papers by Mariko Ogura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariko Ogura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariko Ogura. The network helps show where Mariko Ogura may publish in the future.

Co-authorship network of co-authors of Mariko Ogura

This figure shows the co-authorship network connecting the top 25 collaborators of Mariko Ogura. A scholar is included among the top collaborators of Mariko Ogura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariko Ogura. Mariko Ogura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimozaki, Keitaro, Akira Ooki, Shota Fukuoka, et al.. (2025). Hypoalbuminemia during zolbetuximab plus chemotherapy for claudin 18.2-positive advanced gastric cancer: a need for caution?. SHILAP Revista de lepidopterología. 10. 100257–100257.
2.
Shimozaki, Keitaro, Akira Ooki, Kei Yoshino, et al.. (2025). Managing zolbetuximab-induced nausea and vomiting: a proposal for a pragmatic approach in clinical practice. PubMed. 7. 100128–100128. 4 indexed citations
3.
Wakatsuki, Takeru, Naoki Ishizuka, Shuichi Hironaka, et al.. (2024). Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab. International Journal of Clinical Oncology. 29(6). 801–812. 1 indexed citations
4.
Osumi, Hiroki, Takeru Wakatsuki, Noriko Yamamoto, et al.. (2024). Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan. International Journal of Clinical Oncology. 29(8). 1161–1172. 2 indexed citations
5.
6.
Shimozaki, Keitaro, Izuma Nakayama, Daisuke Takahari, et al.. (2023). Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A Single-Institution Retrospective Study. Journal of the Korean Gastric Cancer Association. 23(4). 609–609. 2 indexed citations
7.
8.
Osumi, Hiroki, Teruko Ueno, Akira Ooki, et al.. (2023). Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab. International Journal of Clinical Oncology. 28(9). 1191–1199.
9.
Wakatsuki, Takeru, Daisuke Takahari, Tomohiro Matsushima, et al.. (2022). Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study. Journal of Gastrointestinal Cancer. 54(2). 475–484. 5 indexed citations
10.
Takahashi, Shunji, Yutaka Fujiwara, Kenji Nakano, et al.. (2021). Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study. Cancer Science. 112(6). 2361–2370. 43 indexed citations
11.
Takahari, Daisuke, Eiji Shinozaki, Takeru Wakatsuki, et al.. (2020). Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research. International Journal of Clinical Oncology. 26(2). 335–344. 6 indexed citations
12.
Suzuki, Takeshi, Akihiko Okamura, Masayuki Watanabe, et al.. (2019). Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 27(5). 1510–1517. 18 indexed citations
13.
Yagi, Shusuke, Takeru Wakatsuki, Noriko Yamamoto, et al.. (2018). Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer. Gastric Cancer. 22(3). 518–525. 57 indexed citations
14.
Mishima, Yuji, Satoshi Matsusaka, Keisho Chìn, et al.. (2017). Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients. Targeted Oncology. 12(3). 341–351. 38 indexed citations
15.
Ogura, Mariko, Yuto Ando, Shigeyoshi Usami, et al.. (2017). Development of sustainable smart society based on transformative electronics. 30.1.1–30.1.4. 2 indexed citations
16.
Suenaga, Mitsukuni, Nobuyuki Mizunuma, Satoshi Matsusaka, et al.. (2015). A phase II study of oxaliplatin reintroduction in patients pretreated with oxaliplatin and irinotecan for advanced colorectal cancer (RE-OPEN study).. Journal of Clinical Oncology. 33(3_suppl). 758–758.
17.
Osumi, Hiroki, Toshiyuki Yoshio, Keisho Chìn, et al.. (2015). Chemotherapy is effective for stage I gastric cancer in patients with synchronous esophageal cancer. Gastric Cancer. 19(2). 625–630. 4 indexed citations
18.
Kuboki, Yasutoshi, Nobuyuki Mizunuma, Masato Ozaka, et al.. (2011). Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer. Oncology Letters. 2(3). 493–498. 10 indexed citations
19.
Matsusaka, Satoshi, Chie Watanabe, Mitsukuni Suenaga, et al.. (2008). [Relative dose intensity of FOLFOX4 regimen].. PubMed. 35(11). 1895–900. 1 indexed citations
20.
Ogura, Mariko, et al.. (2001). 隔週投与CHOP化学療法併用のrHuG-CSF(レノグラスチム)により治療される侵攻型非ホジキンリンパ腫(NHL)患者における長期追跡調査. Blood. 98(11). 344. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natsuko Okita Breakdown of academic impact, for papers by Hiroki Osumi Breakdown of academic impact, for papers by Izuma Nakayama Breakdown of academic impact, for papers by Alessia Mennitto Breakdown of academic impact, for papers by Guoqing Liao Breakdown of academic impact, for papers by Yuichi Arimoto Breakdown of academic impact, for papers by Anna Zamboli Breakdown of academic impact, for papers by Federico Buffoli Breakdown of academic impact, for papers by Giacomo Puppa Breakdown of academic impact, for papers by Yusuke Tajima
Rankless by CCL
2026